| Fingolimod |
EU/1/11/677/003 |
Gilenya, Capsule, hard, 0.5, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma Gmbh Roonstrasse 25 D-90429 Nurnberg, Германия |
2846.81 |
569.36 |
3416.17 |
4% |
10 |
2856.81 |
571.36 |
3428.17 |
16% |
25 |
2881.81 |
576.36 |
3458.17 |
Отхвърлена като неоснователна жалбата от Комисия по прозрачност с решение КП-392/06.11.2015 ; КП-404/15.12.2015 (НСР-4925/22.10.2014) |
НСР-6143/29.04.2015 |
02.12.2015 |
Активен |
2093 |
| Fingolimod |
EU/1/11/677/003 |
Gilenya, Capsule, hard, 0.5, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma Gmbh Roonstrasse 25 D-90429 Nurnberg, Германия |
3028.84 |
605.77 |
3634.61 |
4% |
10 |
3038.84 |
607.77 |
3646.61 |
16% |
25 |
3063.84 |
612.77 |
3676.61 |
|
НСР-1091/02.09.2013 |
19.09.2013 |
Неактивен |
2093 |
| Fingolimod |
EU/1/11/677/003 |
Gilenya, Capsule, hard, 0.5, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma Gmbh Roonstrasse 25 D-90429 Nurnberg, Германия |
3109.14 |
621.83 |
3730.97 |
4% |
10 |
3119.14 |
623.83 |
3742.97 |
16% |
25 |
3144.14 |
628.83 |
3772.97 |
|
КЦРР-1733/04.12.2012 г |
20.12.2012 |
Неактивен |
2093 |
| Afatinib |
EU/1/13/879/009 |
Giotrif, Film‐coated tablet, 40, mg, Pack: 28 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH &Co.KG, Германия |
3334.28 |
666.86 |
4001.14 |
4% |
10 |
3344.28 |
668.86 |
4013.14 |
16% |
25 |
3369.28 |
673.86 |
4043.14 |
|
НСР-7684/10.12.2015. |
26.12.2015 |
Активен |
3175 |
| Afatinib |
EU/1/13/879/006 |
Giotrif, Film‐coated tablet, 30, mg, Pack: 28 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH &Co.KG, Германия |
3334.28 |
666.86 |
4001.14 |
4% |
10 |
3344.28 |
668.86 |
4013.14 |
16% |
25 |
3369.28 |
673.86 |
4043.14 |
|
НСР-7685/10.12.2015. |
26.12.2015 |
Активен |
3174 |
| Afatinib |
EU/1/13/879/006 |
Giotrif, Film‐coated tablet, 30, mg, Pack: 28 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH &Co.KG, Германия |
3509.78 |
701.96 |
4211.74 |
4% |
10 |
3519.78 |
703.96 |
4223.74 |
16% |
25 |
3544.78 |
708.96 |
4253.74 |
|
НСР-4727/26.09.2014 |
10.10.2014 |
Неактивен |
3174 |
| Afatinib |
EU/1/13/879/009 |
Giotrif, Film‐coated tablet, 40, mg, Pack: 28 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH &Co.KG, Германия |
3509.78 |
701.96 |
4211.74 |
4% |
10 |
3519.78 |
703.96 |
4223.74 |
16% |
25 |
3544.78 |
708.96 |
4253.74 |
|
НСР-4727/26.09.2014 |
10.10.2014 |
Неактивен |
3175 |
| Gemcitabine |
20090015 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 200 mg/vial - 10 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma S.R.L., Romania: Actavis Nordic A/S, Denmark |
10.01 |
2 |
12.01 |
6% |
0.6 |
10.61 |
2.12 |
12.73 |
18% |
1.8 |
12.41 |
2.48 |
14.89 |
цената е заличена с решение НСР-7559/19.11.2015 ( в сила от 02.01.2015) |
НСР-5967/01.04.2015. |
16.04.2015 |
Заличен |
3742 |
| Gemcitabine |
20090015 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 1 g/vial - 50 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma S.R.L., Romania: Actavis Nordic A/S, Denmark |
54.92 |
10.98 |
65.9 |
4% |
2.2 |
57.12 |
11.42 |
68.54 |
16% |
8.79 |
65.91 |
13.18 |
79.09 |
цената е заличена с решение НСР-7559/19.11.2015 ( в сила от 02.01.2015) |
НСР-5967/01.04.2015. |
16.04.2015 |
Заличен |
3741 |
| Gemcitabine |
20090015 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 200 mg/vial - 10 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma S.R.L., Romania: Actavis Nordic A/S, Denmark |
11.66 |
2.33 |
13.99 |
6% |
0.7 |
12.36 |
2.47 |
14.83 |
18% |
2.1 |
14.46 |
2.89 |
17.35 |
корекц. Решение НСР-2803/17.02.2014 и НСР-3105/21.03.2014 |
НСР-2508/24.01.2014 |
14.02.2014 |
Неактивен |
3742 |
| Gemcitabine |
20090015 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 1 g/vial - 50 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma S.R.L., Romania: Actavis Nordic A/S, Denmark |
69.92 |
13.98 |
83.9 |
4% |
2.8 |
72.72 |
14.54 |
87.26 |
16% |
11.19 |
83.91 |
16.78 |
100.69 |
|
НСР-2525/24.01.2014 |
14.02.2014 |
Неактивен |
3741 |
| Gemcitabine |
20090015 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 200 mg/vial - 10 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma S.R.L., Romania: Actavis Nordic A/S, Denmark |
16.64 |
3.33 |
19.97 |
6% |
1 |
17.64 |
3.53 |
21.17 |
18% |
3 |
20.64 |
4.13 |
24.77 |
|
КЦРР-2789/20.03.2013 |
24.04.2013 |
Неактивен |
3742 |
| Gemcitabine |
20090015 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 1 g/vial - 50 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma S.R.L., Romania: Actavis Nordic A/S, Denmark |
77.53 |
15.51 |
93.04 |
4% |
3.1 |
80.63 |
16.13 |
96.76 |
16% |
12.4 |
93.03 |
18.61 |
111.64 |
|
КЦРР-2788/20.03.2013 |
24.04.2013 |
Неактивен |
3741 |
| Gemcitabine |
ІІ-4011/19.01.2009 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 200 mg/vial - 10 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma S.R.L., Romania: Actavis Nordic A/S, Denmark |
17.09 |
3.42 |
20.51 |
6% |
1.03 |
18.12 |
3.62 |
21.74 |
18% |
3.08 |
21.2 |
4.24 |
25.44 |
|
КЦРР-1834/12.12.2012 г |
27.12.2012 |
Неактивен |
3742 |
| Gemcitabine |
II-4011/19.01.2009 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 2 g/vial, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C. Sindan Pharma S.R.L., Romania; Actavis Nordic A/S, Denmark; Actavis Italy S.p.A Nerviano, Italy |
155.08 |
31.02 |
186.1 |
4% |
6.2 |
161.28 |
32.26 |
193.54 |
16% |
24.81 |
186.09 |
37.22 |
223.31 |
цената е заличена с решение НСР-941/12.08.2013 |
КЦРР-1834/12.12.2012 г |
27.12.2012 |
Заличен |
1507 |
| Gemcitabine |
ІІ-4012/19.01.2009 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 1 g/vial - 50 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma S.R.L., Romania: Actavis Nordic A/S, Denmark |
85.47 |
17.09 |
102.56 |
4% |
3.42 |
88.89 |
17.78 |
106.67 |
16% |
13.68 |
102.57 |
20.51 |
123.08 |
|
КЦРР-1834/12.12.2012 г |
27.12.2012 |
Неактивен |
3741 |
| Gemcitabine |
№ II-4011/ 19.01.2009 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 2 g/vial, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C. Sindan Pharma S.R.L., Romania; Actavis Nordic A/S, Denmark; Actavis Italy S.p.A Nerviano, Italy |
399.67 |
79.93 |
479.6 |
4% |
10 |
409.67 |
81.93 |
491.6 |
16% |
25 |
434.67 |
86.93 |
521.6 |
|
КЦ-1785/04.10.2010 |
19.10.2010 |
Неактивен |
1507 |
| Gemcitabine |
ІІ-4012/19.01.2009 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 1 g/vial - 50 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma S.R.L., Romania: Actavis Nordic A/S, Denmark |
195.6 |
39.12 |
234.72 |
4% |
7.82 |
203.42 |
40.68 |
244.1 |
16% |
25 |
228.42 |
45.68 |
274.1 |
|
КЦ-1709/09.09.2010 |
28.10.2010 |
Неактивен |
3741 |
| Gemcitabine |
ІІ-4011/19.01.2009 |
GITRABIN, Powder for solution for infusion, 38 mg/ml - 200 mg/vial - 10 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma S.R.L., Romania: Actavis Nordic A/S, Denmark |
39.12 |
7.82 |
46.94 |
4% |
1.56 |
40.68 |
8.14 |
48.82 |
16% |
6.26 |
46.94 |
9.39 |
56.33 |
|
КЦ-1709/09.09.2010 |
28.10.2010 |
Неактивен |
3742 |
| Bimatoprost |
20130262 |
Glabrilux 0.3 mg/ml, Eye drops, solution, 0.3 mg/ml - 3 ml, mg, Pack: 1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Sanitas AB, Литва |
15.63 |
3.13 |
18.76 |
6% |
0.94 |
16.57 |
3.31 |
19.88 |
18% |
2.81 |
19.38 |
3.88 |
23.26 |
корекционно решение НСР-6892/30.07.2015; цената се заличава с решение НСР-6880/30.07.2015 (в сила от 02.09.2015) |
НСР-6552/24.06.2015 |
11.07.2015 |
Заличен |
2654 |
| Bimatoprost |
20130262 |
Glabrilux 0.3 mg/ml, Eye drops, solution, 0.3 mg/ml - 3 ml, mg, Pack: 1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Sanitas AB, Литва |
15.96 |
3.19 |
19.15 |
6% |
0.96 |
16.92 |
3.38 |
20.3 |
18% |
2.87 |
19.79 |
3.96 |
23.75 |
|
НСР-3027/21.03.2014 |
14.04.2014 |
Неактивен |
2654 |
| Latanoprost |
20110646 |
Glautan, Eye drops, solution, 50 mcg/ml-2.5 ml, mcg, Pack: 1 |
Софарма АД, България |
RAFARM SA., Thesi Pousi Hatzi Agion Louka, Piania Attiki 19002, P.O. Box 37 Гърция |
7.28 |
1.46 |
8.74 |
7% |
0.51 |
7.79 |
1.56 |
9.35 |
20% |
1.46 |
9.25 |
1.85 |
11.1 |
цената е заличена с решение НСР-8394/07.03.2016 година (в сила от 02.04.2016 година) |
НСР-2615/03.02.2014 |
21.02.2014 |
Заличен |
2507 |
| Latanoprost |
20110646 |
Glautan, Eye drops, solution, 50 mcg/ml-2.5 ml, mcg, Pack: 1 |
Софарма АД, България |
RAFARM SA., Thesi Pousi Hatzi Agion Louka, Piania Attiki 19002, P.O. Box 37 Гърция |
8.06 |
1.61 |
9.67 |
7% |
0.56 |
8.62 |
1.72 |
10.34 |
20% |
1.61 |
10.23 |
2.05 |
12.28 |
|
КЦРР-2079/24.01.2013 г |
08.02.2013 |
Неактивен |
2507 |
| Latanoprost, Timolol |
20120309 |
Glauxat, Eye drops, solution, 0,05 mg/5mg/ml - 2,5 ml, mg, Pack: 1 |
Софарма АД, България |
RAFARM S.A., Thesi Pousi-Hatzi Agiou Louka, Postbox 37, 19002, Paiania Attica, Athens, Гърция |
8.48 |
1.7 |
10.18 |
7% |
0.59 |
9.07 |
1.81 |
10.88 |
20% |
1.7 |
10.77 |
2.15 |
12.92 |
цената е заличена с решение НСР-8393/07.03.2016 година (в сила от 02.04.2016 година) |
НСР-2614/03.02.2014 |
21.02.2014 |
Заличен |
2508 |
| Latanoprost, Timolol |
20120309 |
Glauxat, Eye drops, solution, 0,05 mg/5mg/ml - 2,5 ml, mg, Pack: 1 |
Софарма АД, България |
RAFARM S.A., Thesi Pousi-Hatzi Agiou Louka, Postbox 37, 19002, Paiania Attica, Athens, Гърция |
12.75 |
2.55 |
15.3 |
6% |
0.77 |
13.52 |
2.7 |
16.22 |
18% |
2.3 |
15.82 |
3.16 |
18.98 |
|
НСР-977/12.08.2013 |
04.09.2013 |
Неактивен |
2508 |